Calico, a Google-founded R&D company focused on aging research and therapeutics, and the Buck Institute for Research on Aging, based in California, have partnered to support research into longevity and age-related diseases. Financial terms have not been disclosed.
Calico will have the opportunity to identify, fund and support innovative research, ranging from basic biology to potential therapies for age-related diseases. Calico has the option to obtain exclusive rights to discoveries made under research it supports. Additionally, Calico will establish and maintain certain science operations at the Buck.
"We are excited to forge this new partnership with Calico, which represents a unique way for academic researchers focused on aging and the biotech industry to work together," said Brian K. Kennedy, Ph.D., Buck Institute president and CEO.
Hal Barron, president of R&D at Calico, said, "Given the Buck's exclusive focus on aging, we believe that there's great potential to increase our understanding of the biology of aging and to accelerate the translation of emerging insights into therapies to help patients with age-related diseases."